欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	DE/H/4278/002
药品名称	Pemetrexed Xellex 500 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
活性成分	pemetrexed 500.0 mg
剂型	Powder for concentrate for solution for infusion
上市许可持有人	Pharma Resources GmbH Domeierstraße 29/31 D-31785 Hameln Germany
参考成员国 - 产品名称	Germany (DE) Pemetrexed PhaRes 500 mg Pulver zur Herstellung eines Konzentrat zur Herstellung einer Infusionslösu
互认成员国 - 产品名称
许可日期	2016/05/17
最近更新日期	2021/02/15
药物ATC编码	L01BA04 pemetrexed
申请类型	TypeLevel1：Known Active Substance TypeLevel2：Additional Strength/Form TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC TypeLevel4：Chemical Substance TypeLevel5：Prescription Only
附件文件下载	PAR \| 01_DE4277-4284_01-02_DC_'_Pemetrexed_PhaRes_Final PARDate of last change:2019/07/02 Final Product Information \| common-final-labop-4278(001)-V001GDate of last change:2019/03/27 Final Product Information \| common-final-labop-4278(002)-V001GDate of last change:2019/03/27 Final Product Information \| common-final-labip-4278(002)-V001GDate of last change:2019/03/27 Final Product Information \| common-final-smpc-4278(001)-V001GDate of last change:2019/03/27 Final Product Information \| common-final-pl-4278(001)-V001GDate of last change:2019/03/27 Final Product Information \| common-final-pl-4278(002)-V001GDate of last change:2019/03/27 Final Product Information \| common-final-smpc-4278(002)-V001GDate of last change:2019/03/27 Final Labelling \| common-labip-4277-peme100mg-v1-141103Date of last change:2016/05/18 Final Labelling \| common-labip-4277-peme500mg-v1-141103Date of last change:2016/05/18 Final Labelling \| common-labop-4277-peme100mg-v1-141103Date of last change:2016/05/18 Final Labelling \| common-labop-4277-peme500mg-v1-141103Date of last change:2016/05/18 Final SPC \| common-smpc-4277-peme100mg-v3-160224Date of last change:2016/05/18 Final SPC \| common-smpc-4277-peme500mg-v3-160224Date of last change:2016/05/18
市场状态	Positive